Medical Insights
FDA Clearance Isn’t Profit: The Pear/Proteus AI Lesson
The narrative surrounding artificial intelligence in healthcare often conflates regulatory clearance with guaranteed clinical efficacy and commercial viability. This dangerous oversimplification, particularly for AI-driven Software…